Phibro Animal Health Corporation

NASDAQ PAHC

Download Data

Phibro Animal Health Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2024: USD 999.51 M

Phibro Animal Health Corporation Revenue is USD 999.51 M for the Trailing 12 Months (TTM) ending March 31, 2024, a 2.18% change year over year. The revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Phibro Animal Health Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 978.17 M, a 7.81% change year over year.
  • Phibro Animal Health Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 907.30 M, a 13.56% change year over year.
  • Phibro Animal Health Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 798.97 M, a -2.37% change year over year.
  • Phibro Animal Health Corporation Revenue for the Trailing 12 Months (TTM) ending March 31, 2020 was USD 818.37 M, a -2.10% change year over year.
NASDAQ: PAHC

Phibro Animal Health Corporation

CEO Mr. Jack Clifford Bendheim
IPO Date April 11, 2014
Location United States
Headquarters Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712
Employees 1,920
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Similar companies

PROC

Procaps Group SA

NA

NA

EGRX

Eagle Pharmaceuticals Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email